As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly ...
Yuri Matischen was part of a group who lobbied for years to build an arena to secure the future of his beloved Sheffield ...
A U.S. judge has ‌rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its ...
A new study found that never-married adults have a higher cancer risk than those who have been married, but the increase risk ...
Prostate problems can begin in your 30s. Know the early warning signs men should never ignore to protect long-term health and ...
ADT intensification may not improve prostate cancer survival. Explore real-world findings and key risk factors. Read more.
Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new ...
Michael Platts panicked when he was diagnosed with prostate cancer. Now he wants to help others break through the stigma and ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
Researchers have discovered that the immune system's T cells can travel to the prostate to provide long-term protection against infections. Their findings suggest we might harness these same ...
Prostate Cancer Study 5 (PCS-5) is a phase III, randomized controlled trial comparing conventionally fractionated radiotherapy (CFRT) vs. hypofractionated radiotherapy (HFRT) exclusively in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results